Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives

Medicinal Chemistry Research

Volumn 23, Issue 2, 2014, Pages 987-994

  Alegaon, Shankar G ^a   Alagawadi, Kallanagouda R ^a   Pawar, Sneha M ^a   Vinod, D ^b   Rajput, Udaysingh ^c  

^a K L E S S COLLEGE OF PHARMACY   (India)

^b MADRAS MEDICAL COLLEGE   (India)

^c Department of Zoology   (India)

Author keywords

Antimicrobial activity; Cytotoxic activity; Drug likeliness; Thiazolidine 2,4 dione

Indexed keywords

2 (5 ARYLIDENE 2,4 DIOXOTHIAZOLIDIN 3 YL)ACETIC ACID DERIVATIVE; 2 [5 (2 CHLORO 5 NITROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (2 CHLOROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (2 HYDROXY 5 NITROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (2,3 DICHLOROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (2,3 DIHYDROXYBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (2,4 DINITROXYBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (4 BROMO 2 FLUOROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (4 BROMO 3 FLUOROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (4 CHLORO 3 NITROBENZYLIDENE) 2,4 DIOXOTHIZOLIDIN 3YL]ACETIC ACID; 2 [5 (FURAN 2 YLMETHYLENE) 2,4 DIOXOTHIZOLIDIN 3 Y])ACETIC ACID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CYTOTOXIC AGENT; KETOCONAZOLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CELL STRAIN A549; CELL STRAIN HT29; CELL STRAIN MCF 7; COLORECTAL CANCER; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; LUNG CANCER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; UTERINE CERVIX CARCINOMA;

EID: 84893765834     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0705-2     Document Type: Article

References (24)

1. Albuquerque JFC, Albuquerque A, Azevedo CC, Thomasson F, Galdino SL, Cantegrel J, Catanho MTJ, Pitta IR, Luu-Duc C (1995) Substituted thiazolidinediones and thio-imidazolidinones:synthesis, structural study and pharmacological activity. Pharmazie 50:387-389.
2. Aydemir N, Bilaloglu R (2003) Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat Res 537:43-51
3. Ayhan-Kilcigil G, Altanlar N (2000) Synthesis of 3-substituted phenacyl-5[2-phenyl-4H-4-oxo-1-benzopyran-6-ylmethyl]-thiazolidine-2,4-diones and evaluation of their antimicrobial activity. Arzneimittelforschung 50:154-157
4. Boyd AS (2007) Thiazolidinedione in dermatology. Int J Derm 46:557-563
5. Bozdag-Dundar O, Ozgen O, Mentese A, Altanlar N, Atli O, Kendi E, Ertan R (2007) Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives. Bioorg Med Chem 15:6012-6017
6. Bruno G, Costantino L, Curinga C, Maccari R, Monforte F, Nicolo F, Ottana R, Vigorita MG (2002) Synthesis and aldose reductase inhibitory activity of 5-arylidine-2,4-thiazolidinediones. Bioorg Med Chem 10:1077-1084
7. Elte JWF, Blickle JF (2007) Thiazolidinediones for the treatment of type 2 diabetes. Eur J Intern Med 18:18-25
8. Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714-3717. (http://www.molinspiration.com/services)
9. Heerding DA, Christmann LT, Clark TJ, Holmes DJ, Rittenhouse SF, Takata DT, Venslavsky JW (2003) New benzylidenethiazolidinedione as antibacterial agents. Bioorg Med Chem Lett 13:3771-3773
10. Heneka MT, Landreth GE (2007) Biochim Biophys Acta 1771:1031-1045
11. Jiang C, Ting AT, Seed B (1998) PPAR-γ agonists inhibits production monocyte inflammatory cytokines. Nature 391:82-86
12. Kalaitzidis RG, Sarafidis PA, Bakeis GL (2009) Effects of thiazolidinediones beyond glycaemic control. Curr Pharm Des 15:529-536
13. Kurebayashi S, Xu X, Ishii S, Shiraishi M, Kouhara H, Kasayama S (2005) A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells. Atherosclerosis 182:71-77
14. Maccari R, Ottana R, Curinga C, Vigorita MG, Rakowitz D, Steindl T, Langer T (2005) Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinedione active as aldose reductase inhibitors. Bioorg Med Chem 13:2809-2823
15. McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, Miranda A, Fulgosi D, Konarski JZ, Kennedy SH (2007) Thiazolidinedione: novel treatments for cognitive deficits in mood disorders. Expert Opin Pharmacother 8:1615-1628
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survrvial. Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
17. National Committee for Clinical Laboratory Standards (2000) Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard document M-7: A5. National Committee for Clinical Laboratory Standards
18. Pallas 3.7.1.2 (2010) ADME-Tox software, CompuDrug International Inc. U.S.A.
19. Prashanth Kumar BR, Karvekar MD, Adhikary L, Nanjan NJ, Suresh B (2006) Microwave induced synthesis of the thiazolidine-2,4-dione motif and the efficient solvent free-solid phase parallel syntheses of 5-benzylidene- thiazolidine-2,4-dione and 5-benzylidene-2-thioxo-thiazolidine-4-one compounds. J Heterocycl Chem 43:897-903
20. Rakowitz D, Maccari R, Ottana R, Vigorita MG (2006) In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones. Bioorg Med Chem 14:567-574
21. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor γ is a negative regulator of macrophage activation. Nature 391:79-82
22. Tan SF, Ang KP, Fong YF (1986) (Z)-and (E)-arylmethylenehydantoins: spectroscopic properties and configuration assignment. J Chem Soc Perkin Trans-2 1941-1944. doi: 10.1039/P29860001941
23. Tuncbilek M, Altanlar N (2006) Synthesis of new 3-(substituted phenacyl)-5-[3-(4H-4-oxo-1-benzopyran-2-yl)-benzylidene]-2,4-thiazolidinediones and their antimicrobial activity. Arch Pharm Chem Life Sci 339:213-216
24. Vogeli U, Philipsborn W, Nagarajan K, Nair MD (1978) Structures of addition products of acetylenedicarboxylic acid esters with various dinucleophiles. An application of C, H-spin-coupling constants. Helv Chim Acta 61:607-617